Page 9 - Rosetrees Trust News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine In those who have not previously been infected and have so far only received one dose of vaccine the immune response to variants of concern may be insufficient. The findings, published today in the journal Science and led by researchers at Queen Mary University of London, Imperial College London and University College London, looked at immune responses in UK healthcare workers at Barts and Royal Free hospitals following their first dose of the Pfizer/BioNTech vaccine. They found that people who had previously had mild or asymptomatic infection had significantly enhanced pr...

Queen Mary University of London In those who have not previously been infected and have so far only received one dose of vaccine the immune response to variants of concern may be insufficient. The findings, published today in the journal Science and led by researchers at Queen Mary University of London, Imperial College London and University College London, looked at immune responses in UK healthcare workers at Barts and Royal Free hospitals following their first dose of the Pfizer/BioNTech vaccine. They found that people who had previously had mild or asymptomatic infection had significantly...

Research has used new MRI techniques to show what is happening in the brains of people with multiple sclerosis in the early stages of their condition. Scientists say these previously unseen changes could have the potential to predict how disabled a person might become in the future.<br />

Electrochemical Sensor Platform for Fast, Sensitive Detection of Biomarkers in Whole Blood Written by AZoSensorsFeb 15 2021 Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment. In patients that have been infected by an unknown pathogen and progress to overt sepsis, every additional hour that an effective antibiotic cannot be administered significantly increases the mortality rate, so time is of utmost essence. The challenge with rapidly diagnosing seps...

 E-Mail IMAGE: Wyss Institute researchers have developed eRapid technology as an affinity-based, low-cost electrochemical diagnostic sensor platform for the multiplexed detection of clinically relevant sepsis biomarkers in whole blood. view more  Credit: Wyss Institute at Harvard University (BOSTON) -- Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment. In patients that have been infected by an unknown pathogen and progress to overt sepsis, e...